Crypto News

5 days ago

Immutep (IMM) Shares Soar 101% Following FDA Orphan Drug Status for Cancer Therapy

Stocks

Immutep (IMM) stock soared 101% after FDA granted Orphan Drug Designation for eftilagimod alfa in soft tissue sarcoma. Market exclusivity & tax benefits await.

The post Immutep (IMM) Shares Soar 101% Following FDA Orphan Drug Status for Cancer Therapy appeared first on Blockonomi.

Source: Blockonomi →

Related News

Trending Category

$ADA$ARB$BITF$BLSH$BMNR$BONK$CLAW Token Scam$DBKSF$ENA$JENNER Token$LUXFF$MATH$MTT token$NIGHT$PUMP$RAY$S$SEA$SOL$SPACE token

Latest News